Insulin Resistance: What It Is, and What You Can Actually Test
Insulin resistance means your cells respond less to insulin, so the pancreas compensates by producing more of it. There is no symptom checklist that identifies it and no insulin test written into clinical guidelines: the standard reference states that measures of insulin resistance have not been integrated into clinical guidelines, so its presence is generally inferred from the clinical presentation. What does exist is ordinary diabetes screening from age 35 (a fasting glucose, a 75 g oral glucose tolerance test, or an A1C), and strong randomized evidence that a lifestyle program cut progression to type 2 diabetes by 58 percent.
Understand the mechanism before the marketing Insulin resistance is a reduced response of muscle, liver and fat tissue to insulin. The pancreas compensates by secreting more insulin, a state called compensatory hyperinsulinemia, which is why blood glucose can read normal for years while insulin is running high.
The compensation is the reason a normal glucose result does not rule it out, and the reason it is described as a process rather than a diagnosis.
Put the prevalence in context Among 6,247 US adults aged 18 to 44 without diabetes, 40.3 percent (95% CI 36.4 to 44.2) met HOMA-IR at or above 2.5 in 2015 to 2018. In the same analysis the figure was 44.8 percent (95% CI 42.0 to 47.6) in 2007 to 2010, with P for trend 0.07, a non significant decline rather than a rise.
The number is high enough to take seriously and flat enough that any source telling you it is exploding is not reading the data it cites.
Stop looking for a self-check Verbatim from the standard clinical reference: measures of insulin resistance have not been integrated into clinical guidelines, and as a result the presence of insulin resistance is generally inferred from the clinical presentation. Acanthosis nigricans, the darkened velvety skin sometimes seen at the neck or armpits, is an associated sign a clinician may note, not a screening tool to use on yourself.
This is the honest ceiling of what is knowable, and it is the exact thing the popular symptom-list videos leave out.
Weight the 10 to 15 year figure correctly The frequently quoted line that insulin resistance precedes type 2 diabetes by 10 to 15 years is a statement in an expert clinical review, not a number measured in a named cohort study.
It is a reasonable framing from a credible source, and it is not the same class of evidence as the prevalence and trial numbers on this page. Labelling it is the difference between informing and overselling.
See what a clinician can order, and what is not worth asking for The American Diabetes Association's 2026 Standards of Care, Section 2, recommends screening all adults from age 35, and treats a fasting plasma glucose, a 2 hour plasma glucose during a 75 g oral glucose tolerance test, and an A1C as each appropriate, repeated at least every 3 years if results are normal. A HOMA-IR is a research measure with no guideline cutoff attached to an action, so it is not a useful thing to request.
Asking for a test that has no threshold to act on produces a number nobody can do anything with. Asking for the guideline screen produces one a clinician can.
See the strongest evidence on this page In the Diabetes Prevention Program, 3,234 adults at high risk were randomized and followed an average of 2.8 years. A lifestyle program targeting at least 7 percent weight loss and 150 minutes a week of activity reduced new type 2 diabetes by 58 percent (95% CI 48 to 66). The metformin arm reduced it by 31 percent (95% CI 17 to 43); metformin is a prescription medication, included here for context, not as a suggestion.
This is a large randomized trial with a hard clinical endpoint, which puts it several rungs above everything else discussed on this page.
If you are 35 or older and have never been screened, ask at your next blood draw Ask for a fasting glucose or an A1C at your next blood draw, and let a clinician read the number in the context of the rest of your health. Do not interpret it yourself, and do not start or change any medication based on a page.
This is the only step here that is both inside the guidelines and inside your control. Everything upstream of it is understanding, not action.
Insulin resistance is genuinely common: in 6,247 US adults aged 18 to 44 without diabetes, 40.3 percent (95% CI 36.4 to 44.2) met a HOMA-IR at or above 2.5 in NHANES 2015 to 2018.
View sources
Insulin Resistance (Freeman, Acevedo, Pennings), StatPearls, NCBI Bookshelf
Diagnosis and Classification of Diabetes: Standards of Care in Diabetes 2026, Section 2 (American Diabetes Association)
Insulin Resistance and Cardiometabolic Risk Profile Among Nondiabetic American Young Adults: Insights From NHANES (Parcha et al., JCEM, 2022)
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin (Knowler et al., NEJM, 2002)
Not medical advice. This page is for education only and is not a substitute for professional medical care. Consult a qualified clinician before changing your health routine.
Editorial disclosure. This protocol is written and fact-checked by the YourProtocol editorial team directly from the primary sources cited below; it is not written or reviewed by any outside expert.
Is this for you
- Anyone who has watched a symptom-list video on insulin resistance and wants the version with the evidence attached
- People deciding whether it is worth asking a clinician for a test, and which test
- Anyone who has been told to request a fasting insulin or a HOMA-IR and wants to know what those numbers can and cannot settle
Cautions
- Educational only, and not a diagnosis: nothing here can tell you whether you have insulin resistance, and no page can
- Only a clinician can interpret a glucose or A1C result in the context of your own health; do not act on a number by yourself
- Metformin is named only because it was a randomized arm of the Diabetes Prevention Program; it is a prescription medication and no dosing is given here
- Acanthosis nigricans is an associated clinical sign, never a self-screening test
- If you already have a diabetes diagnosis or take glucose-lowering medication, this page is not written for your situation; follow your own care team